These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18567082)

  • 1. Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea.
    Nam CW; Shin JW; Park NH
    World J Gastroenterol; 2008 Jun; 14(22):3526-33. PubMed ID: 18567082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
    Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
    J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
    Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
    Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
    Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
    World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
    Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
    Verri C; Roz L; Conte D; Liloglou T; Livio A; Vesin A; Fabbri A; Andriani F; Brambilla C; Tavecchio L; Calarco G; Calabrò E; Mancini A; Tosi D; Bossi P; Field JK; Brambilla E; Sozzi G;
    Am J Respir Crit Care Med; 2009 Mar; 179(5):396-401. PubMed ID: 19096006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHIT mRNA and protein expression in hepatocellular carcinoma.
    Kannangai R; Sahin F; Adegbola O; Ashfaq R; Su GH; Torbenson M
    Mod Pathol; 2004 Jun; 17(6):653-9. PubMed ID: 15060557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
    Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH
    Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between aberrant FHIT transcripts and hepatocellular carcinoma].
    Yu YC; Sun FY; Li Z; Lu SY; Teng XH
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):550-1. PubMed ID: 14552718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
    Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.
    Zhang X; Li HM; Liu Z; Zhou G; Zhang Q; Zhang T; Zhang J; Zhang C
    J Gastroenterol; 2013 Jan; 48(1):132-43. PubMed ID: 22766745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant FHIT transcripts in hepatocellular carcinomas.
    Chen YJ; Chen PH; Chang JG
    Br J Cancer; 1998; 77(3):417-20. PubMed ID: 9472637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers.
    Lee YC; Wu CT; Shih JY; Jou YS; Chang YL
    Br J Cancer; 2004 Jun; 90(12):2378-83. PubMed ID: 15150628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma.
    Xiao YP; Wu DY; Xu L; Xin Y
    World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells.
    Xu RH; Zheng LY; He DL; Tong J; Zheng LP; Zheng WP; Meng J; Xia LP; Wang CJ; Yi JL
    World J Gastroenterol; 2008 Jun; 14(23):3754-8. PubMed ID: 18595145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
    Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
    Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between FHIT and WWOX expression and clinicopathological features in hepatocellular carcinoma].
    Lin J; Wang B; Huang AM; Wang XJ
    Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):357-60. PubMed ID: 20510001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst.
    Malcić A; Jukić S; Anić I; Pavelić B; Kapitanović S; Kruslin B; Pavelić K
    J Oral Pathol Med; 2008 May; 37(5):294-301. PubMed ID: 18221322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.